So Chamath's back in the SPAC game again with American Exceptionalism Acquisition Corp., and honestly, I had to pause and think about what that name even means in this context. The guy's basically become synonymous with SPACs at this point, but here's the thing -- his actual track record tells a pretty different story than the hype suggests.

Let me break down what we're actually looking at with Chamath SPAC performance over the past few years. He was everywhere during the 2020-2021 boom -- SoFi, Virgin Galactic, MP Materials, Clover Health, Opendoor. All these deals got massive attention, and retail investors were piling in thinking they'd found the next big thing. But if you actually look at what happened to most of these positions, the results have been... underwhelming. Some of his companies even ended up delisting or going bankrupt. That's not exactly the track record you want to see from someone positioning themselves as a contrarian genius.

The broader SPAC landscape backs this up too. A study from the University of Florida looked at performance between 2012 and 2022, and the numbers are pretty brutal -- negative 58% returns one year after merger. That's not a typo. And when you look at median SPAC performance across the board from 2009 through 2025, these deals have consistently underperformed the wider market. So it's not just Chamath. The whole structure seems to be working against retail investors more often than not.

Now, there are some winners out there. Hims & Hers has done well riding the GLP-1 wave, Rocket Lab and AST Spacemobile have captured speculation around space, and Vertiv's benefited from AI infrastructure tailwinds. But here's the catch -- these are the exceptions, not the rule. They usually succeed because of specific market catalysts or retail hype, not because the SPAC structure itself is some magic formula.

So what does Chamath SPAC performance history actually tell us about American Exceptionalism? Honestly, it should be a red flag. Not saying it's guaranteed to fail, but between his personal track record and what we know about how SPACs perform overall, approaching this as anything other than a pure speculative bet seems risky. If you're thinking about jumping in, just go in with your eyes open about what the data actually shows.